about htg molecular diagnostics: headquartered in tucson, arizona, htg's mission is to empower precision medicine at the local level. in 2013 the company commercialized its htg edge instrument platform and a portfolio of rna assays that leverage htg's proprietary nuclease protection chemistry. htg's product offerings have since expanded to include its htg edgeseq product line, which automates sample and targeted library preparation for next-generation sequencing. additional information is available at www.htgmolecular.com.
Company profile
Ticker
HTGMQ
Exchange
Website
CEO
John Lubniewski
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
HIGH THROUGHPUT GENOMICS INC, HTG MOLECULAR DIAGNOSTICS INC
SEC CIK
HTGMQ stock data
Latest filings (excl ownership)
25-NSE
Exchange delisting
10 Jul 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8 Jun 23
8-K
Bankruptcy or Receivership
5 Jun 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
24 May 23
8-K
Other Events
16 May 23
10-Q
2023 Q1
Quarterly report
10 May 23
8-K
HTG Molecular Diagnostics Reports First Quarter 2023 Results and Provides Recent Business Highlights
10 May 23
8-K
Other Events
25 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
8-K
Departure of Directors or Certain Officers
3 Feb 23
Transcripts
HTGMQ
Earnings call transcript
2022 Q2
12 Aug 22
HTGMQ
Earnings call transcript
2022 Q1
13 May 22
HTGMQ
Earnings call transcript
2021 Q4
30 Mar 22
HTGMQ
Earnings call transcript
2021 Q3
11 Nov 21
HTGMQ
Earnings call transcript
2021 Q2
13 Aug 21
HTGMQ
Earnings call transcript
2021 Q1
13 May 21
HTGMQ
Earnings call transcript
2020 Q4
26 Mar 21
HTGMQ
Earnings call transcript
2020 Q3
10 Nov 20
HTGMQ
Earnings call transcript
2020 Q2
11 Aug 20
HTGMQ
Earnings call transcript
2020 Q1
13 May 20
Latest ownership filings
4
Stephen Barat
9 Jun 23
4
Stephen Barat
7 Apr 23
SC 13G/A
LYTTON LAURENCE W
13 Feb 23
3
Stephen Barat
10 Feb 23
SC 13G/A
Samjo Capital LLC
10 Feb 23
SC 13G
Cowen Prime Advisors LLC
3 Feb 23
4
Byron Lawson
13 Dec 22
4
John L Lubniewski
13 Dec 22
4
Shaun D McMeans
13 Dec 22
4
Laura Lee Godlewski
13 Dec 22
Financial summary
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.00 mm | 3.00 mm | 3.00 mm | 3.00 mm | 3.00 mm | 3.00 mm |
Cash burn (monthly) | 3.07 mm | 968.17 k | 1.68 mm | 1.68 mm | 1.45 mm | 1.40 mm |
Cash used (since last report) | 36.64 mm | 11.55 mm | 20.09 mm | 20.02 mm | 17.35 mm | 16.73 mm |
Cash remaining | -33.65 mm | -8.55 mm | -17.10 mm | -17.03 mm | -14.36 mm | -13.74 mm |
Runway (months of cash) | -11.0 | -8.8 | -10.2 | -10.1 | -9.9 | -9.8 |
Institutional ownership, Q3 2023
22.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 129.00 k |
Total shares | 495.00 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
AULT Ault Alliance | 470.00 k | $129.00 k |
Hewlett Fund | 25.00 k | $0.00 |
Proequities | 0.00 | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Jun 23 | Stephen Barat | Common Stock | Sell | Dispose S | No | No | 0.8 | 888 | 710.40 | 421 |
31 Mar 23 | Stephen Barat | Common Stock | Payment of exercise | Dispose F | No | No | 2.7 | 52 | 140.40 | 1,309 |
9 Dec 22 | Lawson Byron | Common Stock | Grant | Acquire A | No | No | 0.425 | 1,000 | 425.00 | 6,033 |
9 Dec 22 | McMeans Shaun D | Common Stock | Grant | Acquire A | No | No | 0.425 | 1,000 | 425.00 | 10,570 |